Search Results - "Hsu, Limin"

Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer by JIRALERSPONG, Sao, PALLA, Shana L, GIORDANO, Sharon H, MERIC-BERNSTAM, Funda, LIEDTKE, Cornelia, BARNETT, Chad M, HSU, Limin, HUNG, Mien-Chie, HORTOBAGYI, Gabriel N, GONZALEZ-ANGULO, Ana M

“…Population studies have suggested that metformin use in diabetic patients decreases cancer incidence and mortality. Metformin inhibits the growth of cancer…”
Get full text

Nodal Status and Clinical Outcomes in a Large Cohort of Patients With Triple-Negative Breast Cancer by HERNANDEZ-AYA, Leonel F, CHAVEZ-MACGREGOR, Mariana, GONZALEZ-ANGULO, Ana Maria, XIUDONG LEI, MERIC-BERNSTAM, Funda, BUCHHOLZ, Thomas A, HSU, Limin, SAHIN, Aysegul A, DO, Kim-Anh, VALERO, Vicente, HORTOBAGYI, Gabriel N

“…To evaluate the clinical outcomes and relationship between tumor size, lymph node status, and prognosis in a large cohort of patients with confirmed triple…”
Get full text

Nomogram to Predict Subsequent Brain Metastasis in Patients With Metastatic Breast Cancer by Graesslin, Olivier, Abdulkarim, Bassam S, Coutant, Charles, Huguet, Florence, Gabos, Zsolt, Hsu, Limin, Marpeau, Olivier, Uzan, Serge, Pusztai, Lajos, Strom, Eric A, Hortobagyi, Gabriel N, Rouzier, Roman, Ibrahim, Nuhad K

“…PURPOSE Brain metastasis is usually a fatal event in patients with stage IV breast cancer. We hypothesized that its occurrence can be predicted if a clinical…”
Get full text

Thyroid hormone and breast carcinoma: Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma by CRISTOFANILLI, Massimo, YAMAMURA, Yuko, KAU, Shu-Wan, BEVERS, Therese, STROM, Sara, PATANGAN, Modesto, LIMIN HSU, KRISHNAMURTHY, Savitri, THERIAULT, Richard L, HORTOBAGYI, Gabriel N

“…To investigate the role of primary hypothyroidism (HYPT) on breast carcinogenesis, the authors evaluated 1) the association between HYPT and a diagnosis of…”
Get full text

Prognostic Role of Detection Method and Its Relationship with Tumor Biomarkers in Breast Cancer: The University of Texas M. D. Anderson Cancer Center Experience by Dong, Wenli, Berry, Donald A., Bevers, Therese B., Kau, Shu-Wan, Hsu, Limin, Theriault, Richard L., Shen, Yu

“…Purpose: To assess the effect of tumor detection method (screening versus symptom-based diagnosis) in predicting breast cancer survival and investigate how…”
Get full text

Clinical Characteristics and Outcome of Bone-Only Metastasis in Inflammatory and Noninflammatory Breast Cancers by Kai, Megumi, Kogawa, Takahiro, Liu, Diane D, Fouad, Tamer M, Kai, Kazuharu, Niikura, Naoki, Hsu, Limin, Willey, Jie S, Theriault, Richard L, Valero, Vicente, Ueno, Naoto T

“…Micro-Abstract The clinical course of bone metastasis in inflammatory breast cancer (IBC) has not been well studied. This retrospective study analyzed 50 IBC…”
Get full text

Lipofilling of the Breast Does Not Increase the Risk of Recurrence of Breast Cancer: A Matched Controlled Study by Kronowitz, Steven J., Mandujano, Cosman Camilo, Liu, Jun, Kuerer, Henry M., Smith, Benjamin, Garvey, Patrick, Jagsi, Reshma, Hsu, Limin, Hanson, Summer, Valero, Vicente

“…Although many plastic surgeons perform autologous fat grafting (lipofilling) for breast reconstruction after oncologic surgery, it has not been established…”
Get full text

Systemic therapy for patients with breast cancer and one to three brain metastases (BM) by Soomro, Zaid A, Alhalabi, Omar, Sun, Ryan, Albittar, Aya, Hsu, Limin, Valero, Vicente, Ibrahim, Nuhad K.

“…Abstract only 1090 Background: Despite advances in systemic therapies and improved overall survival of metastatic breast cancer (MBC) patients, the development…”
Get full text

Thyroid hormone and breast carcinoma by Cristofanilli, Massimo, Yamamura, Yuko, Kau, Shu‐Wan, Bevers, Therese, Strom, Sara, Patangan, Modesto, Hsu, Limin, Krishnamurthy, Savitri, Theriault, Richard L., Hortobagyi, Gabriel N.

“…BACKGROUND To investigate the role of primary hypothyroidism (HYPT) on breast carcinogenesis, the authors evaluated 1) the association between HYPT and a…”
Get full text

Effects of systemic therapy and local therapy on outcomes of 873 breast cancer patients with metastatic breast cancer to brain: MD Anderson Cancer Center experience by Gao, Chao, Wang, Fuchenchu, Suki, Dima, Strom, Eric, Li, Jing, Sawaya, Raymond, Hsu, Limin, Raghavendra, Akshara, Tripathy, Debu, Ibrahim, Nuhad K.

“…Outcomes of treatments for patients with breast cancer brain metastasis (BCBM) remain suboptimal, especially for systemic therapy. To evaluate the…”
Get full text

Effect of metformin on survival outcomes in diabetic patients with triple receptor‐negative breast cancer by Bayraktar, Soley, Hernadez‐Aya, Leonel F., Lei, Xiudong, Meric‐Bernstam, Funda, Litton, Jennifer K., Hsu, Limin, Hortobagyi, Gabriel N., Gonzalez‐Angulo, Ana M.

“…BACKGROUND: Recent observational studies have shown that metformin use in diabetic patients decreases both cancer incidence and mortality. Metformin use is…”
Get full text

Effect of neoadjuvant chemotherapy regimen choice in patients with breast cancer with pathologic complete response by Weiss, Anna, Bashour, Sami, Hsu, Limin, Hess, Kenneth R., Thompson, Alastair Mark, Ibrahim, Nuhad K.

“…Abstract only 570 Background: Breast cancer patients with a pathologic complete response (pCR) to neoadjuvant chemotherapy (NACT) have improved survival. We…”
Get full text

Ten-Year Outcomes of Patients With Breast Cancer With Cytologically Confirmed Axillary Lymph Node Metastases and Pathologic Complete Response After Primary Systemic Chemotherapy by Mougalian, Sarah S, Hernandez, Mike, Lei, Xiudong, Lynch, Siobhan, Kuerer, Henry M, Symmans, William F, Theriault, Richard L, Fornage, Bruno D, Hsu, Limin, Buchholz, Thomas A, Sahin, Aysegul A, Hunt, Kelly K, Yang, Wei Tse, Hortobagyi, Gabriel N, Valero, Vicente

“…The long-term effect of axillary pathologic complete response (pCR) on survival among women with breast cancer treated with primary systemic chemotherapy (PST)…”
Get more information

Recurrence and survival outcomes of triple-negative breast cancer survivors disease-free at 5-years and relationship to low hormone receptor positivity (1-9% versus <1%) by Reddy, Sangeetha Meda, Sinha, Arup Kumar, Hsu, Limin, Barcenas, Carlos Hernando, Valero, Vicente

“…Abstract only…”
Get full text

Mammographic breast density is associated with the development of contralateral breast cancer by Raghavendra, Akshara, Sinha, Arup K., Le‐Petross, Huong T., Garg, Naveen, Hsu, Limin, Patangan, Modesto, Bevers, Therese Bartholomew, Shen, Yu, Banu, Arun, Tripathy, Debu, Bedrosian, Isabelle, Barcenas, Carlos H.

“…BACKGROUND Women with dense mammographic breast density (BD) have a 2‐fold increased risk of developing primary breast cancer (BC). The authors hypothesized…”
Get full text

Outcomes in patients with early‐stage breast cancer who underwent a 21‐gene expression assay by Barcenas, Carlos H., Raghavendra, Akshara, Sinha, Arup K., Syed, Masood Pasha, Hsu, Limin, Patangan, Modesto G., Chavez‐MacGregor, Mariana, Shen, Yu, Hortobagyi, Gabriel H., Valero, Vicente, Giordano, Sharon H., Ueno, Naoto T., Tripathy, Debu

“…BACKGROUND Invasive disease‐free survival (IDFS) rates are excellent in patients with breast cancer (BC) with hormone receptor‐positive (HR+), human epidermal…”
Get full text

Breast Cancer Multifocality and Multicentricity and Locoregional Recurrence by Lynch, Siobhan P., Lei, Xiudong, Hsu, Limin, Meric‐Bernstam, Funda, Buchholz, Thomas A., Zhang, Hong, Hortobágyi, Gabriel N., Gonzalez‐Angulo, Ana M., Valero, Vicente

“…Background. The impact of multifocal (MF) or multicentric (MC) breast cancer on locoregional (LR) control rates is unknown. Methods. MF was defined as two or…”
Get full text

Molecular Profiling Using Breast Cancer Subtype to Plan for Breast Reconstruction by Sandberg, Lars Johan, Clemens, Mark W., Symmans, W. F., Valero, Vicente, Caudle, Abigail S., Smith, Benjamin, Kuerer, Henry M., Hsu, Limin, Kronowitz, Steven J.

“…BACKGROUND:Molecular profiling using breast cancer subtype has an increasing role in the multidisciplinary care of the breast cancer patient. We sought to…”
Get full text

Circulating tumor cells in newly diagnosed inflammatory breast cancer by Mego, Michal, Giordano, Antonio, De Giorgi, Ugo, Masuda, Hiroko, Hsu, Limin, Giuliano, Mario, Fouad, Tamer M, Dawood, Shaheenah, Ueno, Naoto T, Valero, Vicente, Andreopoulou, Eleni, Alvarez, Ricardo H, Woodward, Wendy A, Hortobagyi, Gabriel N, Cristofanilli, Massimo, Reuben, James M

“…Circulating tumor cells (CTCs) are an independent prognostic factor for progression-free survival (PFS) and overall survival (OS) in patients with metastatic…”
Get full text

Impact of clinical trial on survival outcomes by Le Du, Fanny, Fujii, Takeo, Park, Minjeong, Liu, Diane, Hsu, Limin, Gonzalez-Angulo, Ana M., Ueno, Naoto T.

“…The number of patients with breast cancer who participate in therapeutic clinical trials remains low. One reason is a lack of opportunity; another is health…”
Get full text